Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  NeuBase Therapeutics, Inc.    NBSE

NEUBASE THERAPEUTICS, INC.

(NBSE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société NEUBASE THERAPEUTICS, INC.
10/14NEUBASE THERAPEUTICS : Announces Addition of Peter Nielsen, Ph.D., Inventor of P..
AQ
10/13NEUBASE THERAPEUTICS : Announces Addition of Peter Nielsen, Ph.D., Inventor of P..
AQ
10/13NeuBase Therapeutics Announces Addition of Peter Nielsen, Ph.D., Inventor of ..
GL
10/06NEUBASE THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creatio..
AQ
09/29NEUBASE THERAPEUTICS : to Present at the Chardan Virtual 4th Annual Genetic Medi..
AQ
09/28NEUBASE THERAPEUTICS : to Present at the Chardan Virtual 4th Annual Genetic Medi..
AQ
09/28NeuBase Therapeutics to Present at the Chardan Virtual 4th Annual Genetic Med..
GL
09/18NEUBASE THERAPEUTICS : to Present at the Myotonic Dystrophy Foundation 2020 Virt..
AQ
09/17NEUBASE THERAPEUTICS : to Present at the Myotonic Dystrophy Foundation 2020 Virt..
AQ
09/17NeuBase Therapeutics to Present at the Myotonic Dystrophy Foundation 2020 Vir..
GL
09/11NEUBASE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (fo..
AQ
09/08NEUBASE THERAPEUTICS : to Present at Upcoming Investor Conferences in September ..
AQ
09/08NeuBase Therapeutics to Present at Upcoming Investor Conferences in September..
GL
08/25NEUBASE THERAPEUTICS : Therapeutic's CEO, Dietrich A. Stephan, Ph.D., to Present..
AQ
08/13NEUBASE THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
08/13NEUBASE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
08/13NEUBASE : Fiscal 3Q Earnings Snapshot
AQ
08/13NeuBase Therapeutics Reports Financial Results for the Third Fiscal Quarter o..
GL
08/13NEUBASE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders..
AQ
07/30NeuBase Therapeutics to Present at the BTIG Virtual Biotechnology Conference ..
GL
07/28NEUBASE THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Ev..
AQ
07/28NeuBase Therapeutics Strengthens Senior Management Team with Appointment of I..
GL
06/30NEUBASE THERAPEUTICS : Added to Russell 3000 and Russell Microcap Indexes
AQ
06/29NeuBase Therapeutics Added to Russell 3000® and Russell Microcap® Indexes
GL
06/24NEUBASE THERAPEUTICS : A letter from GoDaddy CEO Aman Bhutani
PU
06/09NEUBASE THERAPEUTICS, INC. : Other Events (form 8-K)
AQ
05/14NEUBASE THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
05/14NEUBASE : Fiscal 2Q Earnings Snapshot
AQ
05/14NEUBASE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
05/14NeuBase Therapeutics Reports Financial Results for the Second Fiscal Quarter ..
GL
05/11NeuBase Therapeutics to Present at Upcoming Investor Conferences in May 2020
GL
05/01NEUBASE THERAPEUTICS : Announces Closing of Public Offering and Full Exercise of..
AQ
04/30NEUBASE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (fo..
AQ
04/30NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise o..
GL
04/29NEUBASE THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other E..
AQ
04/28NEUBASE THERAPEUTICS : Announces Pricing of $31,500,000 Public Offering of Commo..
AQ
04/27NeuBase Therapeutics Announces Proposed Public Offering of Common Stock
GL
04/03NEUBASE THERAPEUTICS : Financial Statements and Exhibits (form 8-K/A)
AQ
04/03NEUBASE THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and ..
AQ
04/01NEUBASE THERAPEUTICS : Announces Positive, Preclinical Data Validating its Novel..
AQ
03/31NEUBASE THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial S..
AQ
03/31NeuBase Therapeutics Announces Positive, Preclinical Data Validating its Nove..
GL
03/26NEUBASE : Fiscal 1Q Earnings Snapshot
AQ
03/26NEUBASE THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
03/26NEUBASE THERAPEUTICS : Financial Statements and Exhibits (form 8-K/A)
AQ
03/26NEUBASE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
03/26NeuBase Therapeutics Reports Financial Results for the First Fiscal Quarter o..
GL
02/24NEUBASE THERAPEUTICS : Receives Notification of Deficiency from Nasdaq Related t..
AQ
02/21NEUBASE THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continu..
AQ
02/21NeuBase Therapeutics Receives Notification of Deficiency from Nasdaq Related ..
GL
02/18NEUBASE THERAPEUTICS : Changes in Registrant's Certifying Accountant (form 8-K/A..
AQ
02/13NEUBASE THERAPEUTICS, INC. : Changes in Registrant's Certifying Accountant, Non-..
AQ
01/10NEUBASE THERAPEUTICS : 10-K Filing
PU
01/10NEUBASE THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
01/09NEUBASE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
01/09NeuBase Therapeutics Reports Financial Results for Fiscal Year 2019
GL
2019NEUBASE THERAPEUTICS : Wins The Scientist's Top 10 Innovations of 2019 Award for..
AQ
2019NeuBase Therapeutics Wins The Scientist's Top 10 Innovations of 2019 Award fo..
GL
2019NeuBase Therapeutics to Present at Upcoming Investor Conferences in December
GL
2019NeuBase Therapeutics to Present at the Stifel 2019 Healthcare Conference
GL
2019NeuBase Therapeutics Announces Issuance of Foundational Patent Covering the K..
GL
2019NeuBase Therapeutics Announces Appointment of Cancer Biologist and RNA Therap..
GL
2019NeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines C..
GL
2019NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disea..
GL
2019NeuBase Therapeutics Reports Financial Results for the Fiscal Third Quarter ..
GL
2019NeuBase Therapeutics to Ring the NASDAQ Closing Bell Today
GL
2019NeuBase Therapeutics Appoints Danith Ly, Ph.D. as Chief Scientific Officer
GL
Upcoming event on NEUBASE THERAPEUTICS, INC.